Predict your next investment

Asset/Investment Management
sakercapital.com

See what CB Insights has to offer

Investments

3

About Saker Capital

Saker Capital is a specialty real estate investment and advisory firm. Saker Capital specializes in raising capital for proprietary commercial real estate investment opportunities.

Saker Capital Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Saker Capital News

North East biosciences firm receives £250k funding to grow facilities

Aug 19, 2020

A North East biosciences firm has announced that it has received £250k in funding to help grow its workforce and facilities. Magnitude Biosciences, a specialist contract research organisation based in County Durham, received funding from the government’s Coronavirus Future Fund. Current investors in Magnitude Biosciences, Saker Capital and North East Innovation Fund run by Northstar Ventures Capital, have matched the government funds, bringing the total to £250k. The funds will be used to grow the company’s workforce and facilities at NETPark, a technology hub in Sedgefield. David Weinkove, the chief executive of Magnitude Biosciences, commented: “Our automated methods allow us to run many experiments remotely. “This investment allows us to work at full speed while staying COVID-safe in our new lab at NETPark, Sedgefield. We are really happy to employ new people at this difficult time for the local economy.’’ Sean Nicolson from Saker Capital said: “Since its formation Magnitude has expanded the range of services offered and now supports drug discovery in the anti-ageing and neurodegenerative disease fields as well as environmental toxicity testing. “Magnitude’s technology provides rich insights into drug efficacy and mode of action.” Alex Buchan from Northstar Ventures Capital added: ’’Magnitude has demonstrated high agility and resilience during the pandemic and has proven to be a fast growing business in trying times. “Our investment will consolidate its position as a rising contract research services provider to the UK’s biotech sector.’’ Explore these topics

Saker Capital Investments

3 Investments

Saker Capital has made 3 investments. Their latest investment was in Magnitude Biosciences as part of their Convertible Note on August 8, 2020.

CBI Logo

Saker Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/19/2020

Convertible Note

Magnitude Biosciences

$0.3M

No

1

12/2/2019

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

1/17/2019

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/19/2020

12/2/2019

1/17/2019

Round

Convertible Note

Seed VC - II

Seed VC

Company

Magnitude Biosciences

Subscribe to see more

Subscribe to see more

Amount

$0.3M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.